Mesenchymal stromal cells (MSC) for treating immune-mediated inflammation post-transplantation and in autoimmunity

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the evidence for the safety and efficacy of mesenchymal stromal cells (MSC) for treating immune-mediated inflammation post-transplantation of haematopoietic stem cells or solid organs and in autoimmune disease.